Bittensor’s SN68 subnet accelerates drug R&D at Metanova Labs

Bittensor’s SN68 subnet accelerates drug R&D at Metanova Labs

Decentralized AI in drug R&D could democratize discovery, reduce costs, and challenge traditional pharma, but validation hurdles remain. The post Bittensor’s SN68 subnet accelerates drug R&D at Metanova Labs appeared first on Crypto Briefing.

📰 Original Source

Read full article at Cryptobriefing →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.